• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB

DIMERIX LIMITED

1.05% ! 47.0¢
Market Cap $280.6M  !

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB
DXB Media thread.
13 14 15
11:52 852 392K
11:52 Last post  ysaudrey Comments Created with Sketch.  852  Views Created with Sketch.  392K 
DXB
Broker Reports
2 3 4
10:10 191 49K
10:10 Last post  CloseTheMarkets Comments Created with Sketch.  191  Views Created with Sketch.  49K 
DXB 06/11/25 126 28K
06/11/25 Last post  vintage Comments Created with Sketch.  126  Views Created with Sketch.  28K 
DXB
DXB Chart
48 49 50
05/11/25 2.9K 1.2M
05/11/25 Last post  frenchfries57 Comments Created with Sketch.  2.9K  Views Created with Sketch.  1.2M 
DXB 30/10/25 23 4.8K
30/10/25 Last post  RYNZN Comments Created with Sketch.  23  Views Created with Sketch.  4.8K 
DXB 29/10/25 123 21K
29/10/25 Last post  cdoyle Comments Created with Sketch.  123  Views Created with Sketch.  21K 
DXB 22/10/25 0 235
22/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  235 
DXB 22/10/25 0 222
22/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  222 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Appendix 4C and Activities Report
29 Oct 08:35
 
Cleansing Notice
22 Oct 16:20
 
Application for quotation of securities - DXB
22 Oct 16:13
 
Canaccord Drug & Device Conference Investor Presentation
21 Oct 08:31
 
2025 AGM Notice of Meeting, Letter of Access and Proxy
16 Oct 09:03
 
Successful PARASOL Collaboration Data Analysis Outcome
08 Oct 08:37
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
47.0¢
Change
-0.005(1.05%)
Mkt cap ! $280.6M
Open High Low Value Volume
47.0¢ 47.5¢ 46.5¢ $72.53K 154.8K

Buyers (Bids)

No. Vol. Price($)
3 37372 47.0¢
 

Sellers (Offers)

Price($) Vol. No.
47.5¢ 26450 7
View Market Depth
Last trade - 11.27am 10/11/2025 (20 minute delay) ?
Last
47.5¢
  Change
-0.005 ( 0.00 %)
Open High Low Volume
46.5¢ 47.5¢ 46.5¢ 84480
Last updated 11.18am 10/11/2025 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.